
Dolby Family Ventures
Dolby Family Ventures is an early-stage venture capital firm that invests in visionary entrepreneurs tackling complex, long-term problems across precision neuroscience, life sciences platforms, aerospace, digital deep tech, and climate tech. Their strategy involves a long-term, collaborative approach, often co-investing with other funds, and a "polymedicine" approach for complex diseases, prioritizing pre-seed, seed, and Series A investments.
43% of their portfolio is in Biotech & Life Sciences. They made 4 investments in the last 12 months. Their most common stage is series-a (43% of deals). Average disclosed round size is $33.7M (across 23 rounds with reported amounts).
Portfolio
23
Fund Size
$423.1M
Top Stage
Series A
Last 12 Mo
4
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| Seed | $6M | Jan 2026 | |
| Seed | $10M | Dec 2025 | |
| Series A | $25M | Aug 2025 | |
| SSalvia Bioelectronics | Series B | $60M | May 2025 |
| Series B | $29M | Feb 2024 | |
| Series A | $33M | May 2023 | |
| Series A | $22.4M | Apr 2023 | |
| Series B | $88M | Mar 2023 | |
| CCajal Neuroscience | Series A | $96M | Nov 2022 |
| Series B | $43.2M | Nov 2022 | |
| Series B | $25M | Nov 2022 | |
| DDiamond Age | Series A | $50M | Mar 2022 |
| Series C | $85M | Dec 2021 | |
| TTripleBlind | Series A | $24M | Oct 2021 |
| Series A | $70M | Sep 2021 | |
| DDiamond Age | Seed | $8M | Aug 2021 |
| Series A | $20M | Jul 2021 | |
| Series A | $45M | Mar 2018 | |
| Seed | $5M | Nov 2017 | |
| Series B | $14M | Jul 2016 | |
| Series A | $10.3M | Jul 2015 | |
| Seed | $5.5M | Oct 2014 | |
| Pre-Seed | $1M | — |
Top Co-Investors
Last updated: 12 April 2026